Why Should You Attend:
Global companies must meet different product design documentation for the U.S. and the European Union / Common Market. The cGMPs mandate Design Control and the Design History File (DHF). In order to sell globally, the EU's CE-marking documentation is a requirement - the Technical File or Design Dossier. Currently they serve different purposes, support different goals, but the TF/DD is moving in the direction of the DHF. And the DHF may soon borrow some features required in the TF/DD. Being aware of the similarities and differences can further concurrent development / documentation, and/or updates to both. What are DMRs and DHRs relationship to DHFs, TF/DDs?
This webinar will examine the existing and proposed requirements for the FDA's DHF and the MDD's TF/DD - how to meet and document them. Their differing purposes / goals, required and desirable contents and areas requiring frequent re-evaluation / update will be discussed. Similarities and differences, and future convergences and trends will be examined. Typical DHF Table of Contents, Technical File or Design Dossier Table of Contents will be presented.
The importance and usefulness of the "Essential Requirements". Structure of the "Declaration of Conformity"; self-declaring or N-B reviewed. We will also discuss parallel approaches to development, the Device Master Record / Device History Record "tie in" and differing approaches to file audits by the U.S. FDA and a Notified Body.
Areas Covered in the Webinar:
The U.S. FDA's DHF
The EU's MDD and the Technical File / Design Dossier
Design Control 'Over Time' vs. a Product 'Snapshot in Time'
DHF "Typical" Contents
TF / DD Expected Contents
Parallel Approaches to Documentation - Teams
The DMR and DHR - DHF "Deliverables"
Some Future Trends to Consider
FDA and NB Audit Focus
Global companies must meet different product design documentation for the U.S. and the European Union / Common Market. The cGMPs mandate Design Control and the Design History File (DHF). In order to sell globally, the EU's CE-marking documentation is a requirement - the Technical File or Design Dossier. Currently they serve different purposes, support different goals, but the TF/DD is moving in the direction of the DHF. And the DHF may soon borrow some features required in the TF/DD. Being aware of the similarities and differences can further concurrent development / documentation, and/or updates to both. What are DMRs and DHRs relationship to DHFs, TF/DDs?
This webinar will examine the existing and proposed requirements for the FDA's DHF and the MDD's TF/DD - how to meet and document them. Their differing purposes / goals, required and desirable contents and areas requiring frequent re-evaluation / update will be discussed. Similarities and differences, and future convergences and trends will be examined. Typical DHF Table of Contents, Technical File or Design Dossier Table of Contents will be presented.
The importance and usefulness of the "Essential Requirements". Structure of the "Declaration of Conformity"; self-declaring or N-B reviewed. We will also discuss parallel approaches to development, the Device Master Record / Device History Record "tie in" and differing approaches to file audits by the U.S. FDA and a Notified Body.
Areas Covered in the Webinar:
The U.S. FDA's DHF
The EU's MDD and the Technical File / Design Dossier
Design Control 'Over Time' vs. a Product 'Snapshot in Time'
DHF "Typical" Contents
TF / DD Expected Contents
Parallel Approaches to Documentation - Teams
The DMR and DHR - DHF "Deliverables"
Some Future Trends to Consider
FDA and NB Audit Focus
